Edition:
United States

Entellus Medical Inc (ENTL.OQ)

ENTL.OQ on NASDAQ Stock Exchange Global Market

16.07USD
11:09am EST
Change (% chg)

$-0.26 (-1.59%)
Prev Close
$16.33
Open
$16.33
Day's High
$16.57
Day's Low
$16.07
Volume
15,645
Avg. Vol
40,661
52-wk High
$20.34
52-wk Low
$11.48

Chart for

About

Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems,... (more)

Overall

Beta: --
Market Cap(Mil.): $415.99
Shares Outstanding(Mil.): 25.47
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 52.26 15.54
EPS (TTM): -- -- --
ROI: -- 13.49 11.80
ROE: -- 20.00 15.75

BRIEF-Anthem Inc issues positive coverage decision for balloon sinus dilation

* Anthem Inc issues positive coverage decision for balloon sinus dilation

Nov 13 2017

BRIEF-Entellus Medical reports Q3 loss per share $0.13

* Entellus Medical Inc announces third quarter 2017 financial results

Nov 01 2017

BRIEF-Entellus Medical ‍announces data from its human study of Latera absorbable nasal implant from Spirox​

* ‍Announced data from its first-in-human study of Latera absorbable nasal implant from Spirox​

Oct 30 2017

BRIEF-Entellus Medical Q2 loss per share $0.37

* Entellus Medical announces second quarter 2017 financial results

Aug 03 2017

BRIEF-KKR Fund Holdings LP reports 5.5 pct stake in Entellus Medical

* KKR Fund Holdings LP reports 5.5 percent stake in Entellus Medical Inc as of July 13 - SEC filing Source text for Eikon: (http://bit.ly/2ujI08J) Further company coverage:

Jul 21 2017

BRIEF-Entellus Medical borrowes additional $26.5 mln in term loans

* Entellus Medical- ‍on July 13, related to closing of merger with spirox, co borrowed additional $26.5 million in term loans to fund initial cash consideration

Jul 14 2017

BRIEF-Entellus Medical says ‍either party may terminate merger agreement if merger with Spirox is not consummated on or before Dec 31 - SEC Filing​

* Entellus Medical - ‍either party may terminate merger agreement if merger with Spirox is not consummated on or before December 31, 2017 - SEC Filing​

Jul 07 2017

BRIEF-Entellus Medical to acquire Spirox Inc

* Entellus to acquire Spirox for $25 million in cash and 3.4 million shares of entellus common stock

Jul 07 2017

Earnings vs. Estimates